Product Name | MF | CAS | Details |
---|
(3S)-3-amino-3-(4-chlorophenyl)propanoic acid | C9H10ClNO2 | 131690-60-3 | Details |
(3S)-3-amino-3-(4-chlorophenyl)propan-1-ol | C9H12ClNO | 886061-26-3 | Details |
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester | C16H28N2O6 | 189321-65-1 | Details |
(S)-tert-butyl 4-(tert-butoxycarbonylamino)-4-(1-(4-chlorophenyl)-3-hydroxypropylcarbamoyl)piperidine-1-carboxylate | C25H38ClN3O6 | 1143534-57-9 | Details |
(S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)piperidine-4-carboxamide | C15H22ClN3O2 | 1143534-59-1 | Details |
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | C6H4ClN3 | 3680-69-1 | Details |
METHYL 4-((TERT-BUTOXYCARBONYL)AMINO)PIPERIDINE-4-CARBOXYLATE | C12H22N2O4 | 115655-44-2 | Details |
(3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one | C14H20N2O3 | 1383146-20-0 | Details |
3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | C4H6N4OS | 1375066-73-1 | Details |
(R)-3-METHYLPIPERAZIN-2-ONE | C5H10N2O | 922178-61-8 | Details |
Deucravacitinib | C9H12N2O5 | 649729-45-3 | Details |
Deucravacitinib | C5H4N2O4 | 1442437-21-9 | Details |
Deucravacitinib | C5H5Cl2LiN2O3 | 2245111-15-1 | Details |
Elacestrant | C17H16O2 | 32263-70-0 | Details |
Macitentan | C13H14BrClN4O2S | 1393813-42-7 | Details |
Deucravacitinib | C7H6Cl2N2O2 | 679406-03-2 | Details |
Infigratinib | C8H9Cl2NO2 | 872509-56-3 | Details |
Elacestrant | C17H19NO2 | 722520-36-7 | Details |
Deucravacitinib | C10H10N4O3 | 1609394-08-2 | Details |
Infigratinib | C12H19N3 | 115619-01-7 | Details |
Macitentan | C10H7BrN2O2 | 706811-25-8 | Details |
Elacestrant | C9H8O3 | 34841-47-9 | Details |
Zavegepant | C11H10N2O3 | 868707-31-7 | Details |
Infigratinib | C26H31Cl2N7O3 | 872511-34-7 | Details |
Rimegepant | C15H16N6O2 | 1373116-06-3 | Details |
Infigratinib | C17H24N6 | 872511-35-8 | Details |
Elacestrant | C17H15BrO | 722536-73-4 | Details |
Zavegepant | C14H17ClN2O | 855778-84-6 | Details |
Elacestrant | C19H23NO2 | 722520-42-5 | Details |
Zavegepant | C11H14ClN3O2 | 1414976-15-0 | Details |
Rimegepant | C16H16F2N2O | 1373116-05-2 | Details |
Elacestrant | C7H8BrNO | 59557-92-5 | Details |
Deucravacitinib | C16H16ClN7O2 | 1609394-23-1 | Details |
Macitentan | C15H19BrN4O4S | 1393813-43-8 | Details |
Elacestrant | C7H8BNO5 | 860034-09-9 | Details |
Fezolinetant | C16H24N2O3 | 1429560-52-0 | Details |
Deucravacitinib | C7H8N2O4 | 1352925-63-3 | Details |
Macitentan | C10H5BrCl2N2 | 146533-41-7 | Details |
Lumateperone | C16H19N3O3 | 313369-16-3 | Details |
Rimegepant | C25H33F2NO2Si | 1190363-46-2 | Details |
Ergothioneine | C9H15N3O2S | 497-30-3 | Details |
Ectoine | C6H10N2O2 | 96702-03-3 | Details |
Spermidine | C7H19N3 | 124-20-9 | Details |
DIPALMITOYL HYDROXYPROLINE | C37H69NO5 | 41672-81-5 | Details |
Sodiumtetrahydrojasmonate | C12H23NaO3 | 1175006-92-4 | Details |
7-methoxy-2,2-dimethylchroman-6-ylpalmitate | C28H46O4 | 1105025-85-1 | Details |
4-nitroso-1,3-dihydroquinoxalin-2-one | C8H7N3O2 | 53374-52-0 | Details |
N-Carbethoxy-4-piperidone | C8H13NO3 | 29976-53-2 | Details |
phenyl N-[(E)-(5-nitrofuran-2-yl)methylideneamino]carbamate | C17H21N3O3 | 313369-25-4 | Details |
(2S)-Hydroxy(phenyl)acetic acid-(4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (1:1) | C19H21BrN2O3 | 1059630-13-5 | Details |
Deucravacitinib | C9H9NO5 | 90564-26-4 | Details |
Deucravacitinib | C8H8N2O4 | 722538-98-9 | Details |
Deucravacitinib | C9H8N4O3 | 1609394-05-9 | Details |
Deucravacitinib | C10H12N4O | 1609394-10-6 | Details |
Deucravacitinib | C6H2Cl2D3N3O | 1609393-89-6 | Details |
Deucravacitinib | C4H7NO | 6228-73-5 | Details |
6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride | C11H12BrClN2 | 1059630-11-3 | Details |
(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate | C17H23N3O2 | 313369-26-5 | Details |
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-3-methyl-, (6bR,10aS) | C14H19N3 | 313368-85-3 | Details |
4-Chloro-p-fluorobutyrophenone | C10H10ClFO | 3874-54-2 | Details |
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,9,10-tetrahydro-2-oxo-, ethyl ester | C16H17N3O3 | 313544-31-9 | Details |
2(1H)-Quinoxalinone,3,4-dihydro-; 1,2,3,4-Tetrahydro-2-quinoxali | C8H8N2O | 59564-59-9 | Details |
Calcifediol | C27H44O2 | 19356-17-3 | Details |
Fisetin | C15H10O6 | 528-48-3 | Details |
Anserine | C10H16N4O3 | 584-85-0 | Details |
Cholesterol | C27H46O | 57-88-5 | Details |
DIAMINOPYRIMIDINE OXIDE | C4H6N4O | Details |
Omaveloxolone (RTA 408) | C33H44F2N2O3 | 1474034-05-3 | Details |
Product Total: Product Page: | ||||
1 |